1. Home
  2. BCV vs EDAP Comparison

BCV vs EDAP Comparison

Compare BCV & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bancroft Fund Ltd.

BCV

Bancroft Fund Ltd.

HOLD

Current Price

$23.93

Market Cap

128.4M

Sector

Finance

ML Signal

HOLD

Logo EDAP TMS S.A.

EDAP

EDAP TMS S.A.

HOLD

Current Price

$3.45

Market Cap

128.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCV
EDAP
Founded
1971
1979
Country
United States
France
Employees
N/A
289
Industry
Finance/Investors Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
128.4M
128.9M
IPO Year
N/A
1998

Fundamental Metrics

Financial Performance
Metric
BCV
EDAP
Price
$23.93
$3.45
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
20.2K
32.0K
Earning Date
01-01-0001
05-07-2026
Dividend Yield
8.13%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$70,527,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$6.13
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.63
52 Week Low
$16.36
$1.21
52 Week High
$24.55
$5.05

Technical Indicators

Market Signals
Indicator
BCV
EDAP
Relative Strength Index (RSI) 64.26 38.73
Support Level $22.84 $3.19
Resistance Level $24.55 $3.44
Average True Range (ATR) 0.46 0.25
MACD 0.16 0.02
Stochastic Oscillator 83.82 35.34

Price Performance

Historical Comparison
BCV
EDAP

About BCV Bancroft Fund Ltd.

Bancroft Fund Ltd is a diversified closed-end management company. It operates as a closed-ended equity mutual fund. The funds' main objective is to provide income and potential for capital appreciation. With the intent to achieve its objective, the company invests in convertible and equity securities. It invests across different industries such as Computer Software and Services, Energy and Utilities, Health Care among others.

About EDAP EDAP TMS S.A.

Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.

Share on Social Networks: